US Patent 8012750 T-cell activation device
Patent 8012750 was granted and assigned to Immunovative Therapies on September, 2011 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 8012750 T-cell activation device
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.